LALPATHLABHealthcare Service Provider
Dr Lal PathLabs Ltd — Cash Flow Statement
₹1325.40
-0.17%
Dr Lal PathLabs Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 515.01 Cr | 477.90 Cr | 411.46 Cr | -29.40 Cr | — |
| Repayment Of Debt | -83.33 Cr | -153.34 Cr | -108.98 Cr | 0.00 | — |
| Issuance Of Capital Stock | 12.70 Cr | 3.49 Cr | 0.87 Cr | 0.20 Cr | — |
| Capital Expenditure | -53.87 Cr | -57.43 Cr | -44.57 Cr | -476.10 Cr | — |
| End Cash Position | 292.63 Cr | 360.93 Cr | 263.73 Cr | 378.20 Cr | — |
| Beginning Cash Position | 360.93 Cr | 263.73 Cr | 378.19 Cr | 244.30 Cr | — |
| Changes In Cash | -68.31 Cr | 97.20 Cr | -114.46 Cr | 133.90 Cr | — |
| Financing Cash Flow | -334.03 Cr | -413.86 Cr | -283.18 Cr | 136.40 Cr | — |
| Interest Paid Cff | -22.30 Cr | -29.36 Cr | -37.72 Cr | -30.40 Cr | — |
| Cash Dividends Paid | -207.30 Cr | -201.17 Cr | -103.01 Cr | -116.70 Cr | — |
| Common Stock Dividend Paid | -207.30 Cr | -201.17 Cr | -103.01 Cr | -116.66 Cr | — |
| Net Common Stock Issuance | 12.70 Cr | 3.49 Cr | 0.87 Cr | 0.20 Cr | — |
| Common Stock Issuance | 12.70 Cr | 3.49 Cr | 0.87 Cr | 0.20 Cr | — |
| Net Issuance Payments Of Debt | -83.33 Cr | -153.34 Cr | -108.98 Cr | 345.40 Cr | — |
| Net Long Term Debt Issuance | -83.33 Cr | -153.34 Cr | -108.98 Cr | 345.40 Cr | — |
| Long Term Debt Payments | -83.33 Cr | -153.34 Cr | -108.98 Cr | 0.00 | — |
| Investing Cash Flow | -303.16 Cr | -24.27 Cr | -287.31 Cr | -449.20 Cr | — |
| Net Other Investing Changes | 3.47 Cr | 2.01 Cr | — | — | — |
| Interest Received Cfi | 63.12 Cr | 45.34 Cr | 30.63 Cr | 49.60 Cr | — |
| Net Investment Purchase And Sale | -316.55 Cr | -14.71 Cr | -256.05 Cr | 433.30 Cr | — |
| Sale Of Investment | 1.26K Cr | 967.07 Cr | 878.64 Cr | 1.28K Cr | — |
| Purchase Of Investment | -1.57K Cr | -981.78 Cr | -1.13K Cr | -847.60 Cr | — |
| Net Business Purchase And Sale | 0.00 | -0.35 Cr | -17.82 Cr | -457.60 Cr | — |
| Purchase Of Business | 0.00 | -0.35 Cr | -17.82 Cr | -457.60 Cr | — |
| Net Intangibles Purchase And Sale | -9.58 Cr | -6.27 Cr | -8.05 Cr | -382.00 Cr | — |
| Purchase Of Intangibles | -9.58 Cr | -6.27 Cr | -8.05 Cr | -382.00 Cr | — |
| Net PPE Purchase And Sale | -43.62 Cr | -50.29 Cr | -36.01 Cr | -92.50 Cr | — |
| Sale Of PPE | 0.67 Cr | 0.88 Cr | 0.50 Cr | 1.60 Cr | — |
| Purchase Of PPE | -44.29 Cr | -51.17 Cr | -36.52 Cr | -94.10 Cr | — |
| Operating Cash Flow | 568.88 Cr | 535.33 Cr | 456.03 Cr | 446.70 Cr | — |
| Taxes Refund Paid | -163.90 Cr | -132.03 Cr | -106.43 Cr | -130.00 Cr | — |
| Change In Working Capital | 6.01 Cr | 35.74 Cr | 35.48 Cr | -16.70 Cr | — |
| Change In Other Current Liabilities | 12.12 Cr | 9.38 Cr | -0.93 Cr | 16.00 Cr | — |
| Change In Other Current Assets | -3.67 Cr | -2.16 Cr | 3.27 Cr | -17.70 Cr | — |
| Change In Payable | 12.28 Cr | 30.47 Cr | 9.23 Cr | 3.40 Cr | — |
| Change In Inventory | 1.18 Cr | -3.50 Cr | 18.73 Cr | -10.00 Cr | — |
| Change In Receivables | -15.11 Cr | -7.18 Cr | 3.09 Cr | -18.20 Cr | — |
| Other Non Cash Items | -47.96 Cr | -29.01 Cr | 3.92 Cr | -17.00 Cr | — |
| Stock Based Compensation | 27.09 Cr | 21.71 Cr | 22.81 Cr | 32.30 Cr | — |
| Provisionand Write Offof Assets | 3.45 Cr | -0.27 Cr | 7.59 Cr | -1.30 Cr | — |
| Deferred Tax | 132.55 Cr | 143.16 Cr | 102.75 Cr | 124.60 Cr | — |
| Depreciation And Amortization | 141.92 Cr | 143.60 Cr | 150.19 Cr | 108.10 Cr | — |
| Amortization Cash Flow | 60.69 Cr | 60.15 Cr | 60.41 Cr | — | — |
| Depreciation | 81.23 Cr | 83.45 Cr | 89.78 Cr | 108.10 Cr | — |
| Pension And Employee Benefit Expense | -4.89 Cr | -0.46 Cr | 2.61 Cr | -1.70 Cr | — |
| Gain Loss On Investment Securities | -20.93 Cr | -10.40 Cr | -6.42 Cr | -3.10 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 0.01 Cr | -0.20 Cr | -0.38 Cr | 0.00 | — |
| Gain Loss On Sale Of PPE | 2.15 Cr | 0.22 Cr | -0.81 Cr | 0.60 Cr | — |
| Net Income From Continuing Operations | 492.25 Cr | 362.29 Cr | 241.08 Cr | 350.30 Cr | — |
| Issuance Of Debt | — | 0.00 | 0.00 | 345.40 Cr | 0.00 |
| Long Term Debt Issuance | — | 0.00 | 0.00 | 345.40 Cr | 0.00 |
| Net Other Financing Charges | — | — | -0.14 Cr | — | -10000.00 |
| Other Cash Adjustment Outside Changein Cash | — | — | — | -10000.00 | — |
| Net Preferred Stock Issuance | — | — | — | 0.00 | 0.15 Cr |
| Preferred Stock Issuance | — | — | — | 0.00 | 0.15 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Dr Lal PathLabs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.